Johnson & Johnson Sees $1.57M in Bearish Put Flow as Stock Trades Near 52-Week Highs
By TrendSpider Editor
Two unusual put contracts totaling $1,566,919.80 in premium hit the tape for Johnson & Johnson on Wednesday, drawing attention as the stock trades near the upper end of its 52-week range. JNJ is currently priced at $238.48, up 0.62% on the session, and sits well above the 52-week low of $149.04 with
Johnson & Johnson Sees $1.57M in Bearish Put Flow as Stock Trades Near 52-Week Highs
Two unusual put contracts totaling $1,566,919.80 in premium hit the tape for Johnson & Johnson on Wednesday, drawing attention as the stock trades near the upper end of its 52-week range. JNJ is currently priced at $238.48, up 0.62% on the session, and sits well above the 52-week low of $149.04 with the 52-week high at $251.705. The concentration of bearish flow at the $230 strike stands out given the stock's elevated positioning heading into summer.
Key Drivers of the JNJ Stock Move
- Main Catalyst: Two put contracts at the $230 strike expiring July 2, 2026 were flagged as unusual. The first carried a size of 438 contracts and a premium of $88,519.80 with an open interest percentage of 932%. The second was significantly larger, with a size of 7,040 contracts and a premium of $1,478,400, representing a massive 14,979% of open interest. Both contracts are out of the money relative to the current price of $238.48.
- Bull Case: JNJ is trading at $238.48, roughly $8.48 above the $230 put strike, meaning the stock would need to fall more than 3.5% before these puts move into the money at expiration on July 2. The stock's continued grind higher, with a 0.62% gain today, reflects underlying buying interest, and the 52-week high of $251.705 remains a reasonable near-term target for bulls.
- Bear Case: The 7,040-contract put block at 14,979% of open interest is a striking signal. That level of activity relative to existing open interest suggests a large, deliberate directional bet rather than a routine hedge. With expiration just over three weeks away on July 2, the position carries urgency, and a move toward $230 would represent a notable pullback from current levels.
The forward setup for JNJ warrants attention given the size and concentration of today's put flow. The $230 strike acts as a near-term technical reference point, and traders will be watching whether price holds above that level into the July 2 expiration. JNJ has had a wide trading range over the past year, from $149.04 to $251.705, and the current price of $238.48 places it in the upper quartile of that range. Whether today's put activity represents a directional bet on a pullback or a hedge against a large long equity position, the sheer premium deployed in the 7,040-contract block makes it one of the more significant single options prints in the name recently.
JNJ Unusual Options Activity
- Contract 1: Put, $230 strike, expiring July 2, 2026 | Volume: 438 | Open Interest: 932% of prior OI | Out of the Money | Premium: $88,519.80
- Contract 2: Put, $230 strike, expiring July 2, 2026 | Volume: 7,040 | Open Interest: 14,979% of prior OI | Out of the Money | Premium: $1,478,400
Both contracts share the same strike and expiration, with total premium across the two prints reaching $1,566,919.80. The outsized open interest percentages on both contracts indicate this activity represents fresh positioning rather than a continuation of existing trades, with the second contract being one of the more aggressive single put prints seen in the name given its scale relative to prior open interest.
JNJ Seasonality
June and early July historically represent a transitional period for large-cap healthcare names, with quarterly earnings catalysts approaching and institutional portfolio rebalancing common ahead of mid-year. With the July 2 expiration falling just ahead of the typical mid-July earnings window, the timing of this put positioning may be noteworthy for traders monitoring JNJ's next fundamental catalyst.
JNJ Relative Performance
JNJ's 0.62% gain on Wednesday places it modestly in positive territory, trading at $238.48 against a broad 52-week range of $149.04 to $251.705. The stock is currently within approximately 5.4% of its 52-week high, indicating relative strength within the healthcare sector even as today's unusual options flow introduces a note of caution about near-term directional risk.